187 related articles for article (PubMed ID: 32773662)
1. Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children.
Srivastava S; van Zyl J; Cirrincione K; Martin K; Thomas T; Deshpande D; Alffenaar JW; Seddon JA; Gumbo T
Pediatr Infect Dis J; 2020 Dec; 39(12):1092-1100. PubMed ID: 32773662
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.
Deshpande D; Srivastava S; Bendet P; Martin KR; Cirrincione KN; Lee PS; Pasipanodya JG; Dheda K; Gumbo T
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180526
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant
Srivastava S; Gumbo T; Thomas T
Front Pharmacol; 2021; 12():776969. PubMed ID: 34744753
[No Abstract] [Full Text] [Related]
4. Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
Deshpande D; Pasipanodya JG; Srivastava S; Bendet P; Koeuth T; Bhavnani SM; Ambrose PG; Smythe W; McIlleron H; Thwaites G; Gumusboga M; Van Deun A; Gumbo T
Clin Infect Dis; 2018 Nov; 67(suppl_3):S274-S283. PubMed ID: 30496459
[TBL] [Abstract][Full Text] [Related]
5. The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.
Deshpande D; Srivastava S; Chapagain ML; Lee PS; Cirrincione KN; Pasipanodya JG; Gumbo T
J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i36-i42. PubMed ID: 28922808
[TBL] [Abstract][Full Text] [Related]
6. d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Deshpande D; Alffenaar JC; Köser CU; Dheda K; Chapagain ML; Simbar N; Schön T; Sturkenboom MGG; McIlleron H; Lee PS; Koeuth T; Mpagama SG; Banu S; Foongladda S; Ogarkov O; Pholwat S; Houpt ER; Heysell SK; Gumbo T
Clin Infect Dis; 2018 Nov; 67(suppl_3):S308-S316. PubMed ID: 30496460
[TBL] [Abstract][Full Text] [Related]
7. Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.
Deshpande D; Srivastava S; Chapagain M; Magombedze G; Martin KR; Cirrincione KN; Lee PS; Koeuth T; Dheda K; Gumbo T
Sci Adv; 2017 Aug; 3(8):e1701102. PubMed ID: 28875168
[TBL] [Abstract][Full Text] [Related]
8. Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.
van Rijn SP; Srivastava S; Wessels MA; van Soolingen D; Alffenaar JC; Gumbo T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696238
[TBL] [Abstract][Full Text] [Related]
9. Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant
Singh S; Gumbo T; Boorgula GD; Thomas TA; Philley JV; Srivastava S
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0108023. PubMed ID: 38131673
[TBL] [Abstract][Full Text] [Related]
10. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
[TBL] [Abstract][Full Text] [Related]
11. In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.
Jeena PM; Bishai WR; Pasipanodya JG; Gumbo T
Antimicrob Agents Chemother; 2011 Feb; 55(2):539-45. PubMed ID: 21098246
[TBL] [Abstract][Full Text] [Related]
12. Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis.
Srivastava S; Modongo C; Siyambalapitiyage Dona CW; Pasipanodya JG; Deshpande D; Gumbo T
Antimicrob Agents Chemother; 2016 Oct; 60(10):5922-7. PubMed ID: 27458215
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients.
Stein GE; Smith CL; Scharmen A; Kidd JM; Cooper C; Kuti J; Mitra S; Nicolau DP; Havlichek DH
Surg Infect (Larchmt); 2019 Jan; 20(1):55-61. PubMed ID: 30351195
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.
Pasipanodya JG; Nuermberger E; Romero K; Hanna D; Gumbo T
Clin Infect Dis; 2015 Aug; 61 Suppl 1():S10-7. PubMed ID: 26224767
[TBL] [Abstract][Full Text] [Related]
15. Potency of vancomycin against Mycobacterium tuberculosis in the hollow fiber system model.
Srivastava S; Chapagain M; van Zyl J; Deshpande D; Gumbo T
J Glob Antimicrob Resist; 2021 Mar; 24():403-410. PubMed ID: 33508482
[TBL] [Abstract][Full Text] [Related]
16. Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.
Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
Clin Infect Dis; 2016 Nov; 63(suppl 3):S88-S94. PubMed ID: 27742639
[TBL] [Abstract][Full Text] [Related]
17. Once-a-week tigecycline for the treatment of drug-resistant TB.
Deshpande D; Magombedze G; Srivastava S; Bendet P; Lee PS; Cirrincione KN; Martin KR; Dheda K; Gumbo T
J Antimicrob Chemother; 2019 Jun; 74(6):1607-1617. PubMed ID: 30820554
[TBL] [Abstract][Full Text] [Related]
18. Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
Gumbo T; Pasipanodya JG; Nuermberger E; Romero K; Hanna D
Clin Infect Dis; 2015 Aug; 61 Suppl 1():S18-24. PubMed ID: 26224768
[TBL] [Abstract][Full Text] [Related]
19. Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.
Srivastava S; Deshpande D; Pasipanodya J; Nuermberger E; Swaminathan S; Gumbo T
Clin Infect Dis; 2016 Nov; 63(suppl 3):S102-S109. PubMed ID: 27742641
[TBL] [Abstract][Full Text] [Related]
20. Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against
Srivastava S; Thomas T; Howe D; Malinga L; Raj P; Alffenaar JW; Gumbo T
Front Pharmacol; 2021; 12():677005. PubMed ID: 34163361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
